Medivolve Inc. (MEDVF)
USD 0.01
(133.33%)
USD 0.01
(133.33%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.03 CAD | 10.29% |
| 2022 | -0.68 CAD | -100.0% |
| 2021 | -0.34 CAD | 93.99% |
| 2020 | -5.66 CAD | -375.63% |
| 2019 | -1.19 CAD | -283.87% |
| 2018 | -0.31 CAD | -122.96% |
| 2017 | 1.35 CAD | 328.81% |
| 2016 | -0.59 CAD | 76.21% |
| 2015 | -2.48 CAD | 45.37% |
| 2014 | -4.54 CAD | 65.81% |
| 2013 | -13.28 CAD | -77.54% |
| 2012 | -7.48 CAD | -53.28% |
| 2011 | -4.88 CAD | 33.7% |
| 2010 | -7.36 CAD | 19.65% |
| 2009 | -9.16 CAD | 29.59% |
| 2008 | -13.01 CAD | -584.74% |
| 2007 | -1.90 CAD | -15.15% |
| 2006 | -1.65 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.03 CAD | 93.0% |
| 2023 Q3 | -0.13 CAD | -111.04% |
| 2023 FY | - CAD | 10.29% |
| 2023 Q4 | -0.31 CAD | -138.46% |
| 2023 Q1 | -0.11 CAD | 26.67% |
| 2023 Q2 | -0.06 CAD | 44.0% |
| 2022 Q4 | -0.15 CAD | 42.31% |
| 2022 Q3 | -0.26 CAD | -18.18% |
| 2022 Q2 | -0.22 CAD | -313.53% |
| 2022 FY | - CAD | -100.0% |
| 2022 Q1 | -0.05 CAD | -135.47% |
| 2021 FY | - CAD | 93.99% |
| 2021 Q1 | -0.78 CAD | 76.15% |
| 2021 Q2 | -0.63 CAD | 19.23% |
| 2021 Q3 | 0.30 CAD | 147.62% |
| 2021 Q4 | 0.15 CAD | -50.0% |
| 2020 Q4 | -3.27 CAD | -760.53% |
| 2020 FY | - CAD | -375.63% |
| 2020 Q1 | -0.53 CAD | -76.67% |
| 2020 Q2 | -1.17 CAD | -120.75% |
| 2020 Q3 | -0.38 CAD | 67.52% |
| 2019 Q3 | -0.34 CAD | 5.56% |
| 2019 FY | - CAD | -283.87% |
| 2019 Q1 | -0.20 CAD | -198.95% |
| 2019 Q2 | -0.36 CAD | -80.0% |
| 2019 Q4 | -0.30 CAD | 11.76% |
| 2018 Q4 | -0.07 CAD | 48.54% |
| 2018 Q3 | -0.13 CAD | -172.54% |
| 2018 Q2 | -0.05 CAD | 29.85% |
| 2018 FY | - CAD | -122.96% |
| 2018 Q1 | -0.07 CAD | -103.8% |
| 2017 Q4 | 1.79 CAD | 1727.27% |
| 2017 FY | - CAD | 328.81% |
| 2017 Q3 | -0.11 CAD | 21.43% |
| 2017 Q2 | -0.14 CAD | 0.0% |
| 2017 Q1 | -0.14 CAD | 53.33% |
| 2016 Q3 | 0.05 CAD | 138.77% |
| 2016 Q2 | -0.13 CAD | -8.33% |
| 2016 Q1 | -0.12 CAD | 85.54% |
| 2016 FY | - CAD | 76.21% |
| 2016 Q4 | -0.30 CAD | -695.24% |
| 2015 FY | - CAD | 45.37% |
| 2015 Q4 | -0.83 CAD | -33.87% |
| 2015 Q3 | -0.62 CAD | -31.91% |
| 2015 Q2 | -0.47 CAD | 22.95% |
| 2015 Q1 | -0.61 CAD | 56.74% |
| 2014 Q2 | -1.56 CAD | -102.6% |
| 2014 Q1 | -0.77 CAD | 45.77% |
| 2014 Q3 | -0.79 CAD | 49.36% |
| 2014 FY | - CAD | 65.81% |
| 2014 Q4 | -1.41 CAD | -78.48% |
| 2013 Q3 | -0.98 CAD | 1.01% |
| 2013 Q1 | -9.90 CAD | 0.0% |
| 2013 Q2 | -0.99 CAD | 90.0% |
| 2013 Q4 | -1.42 CAD | -44.9% |
| 2013 FY | - CAD | -77.54% |
| 2012 FY | - CAD | -53.28% |
| 2012 Q4 | - CAD | 100.0% |
| 2012 Q3 | -0.89 CAD | -9.88% |
| 2012 Q2 | -0.81 CAD | 35.71% |
| 2012 Q1 | -1.26 CAD | 0.0% |
| 2011 Q3 | -0.57 CAD | 78.97% |
| 2011 Q1 | -1.30 CAD | 0.0% |
| 2011 FY | - CAD | 33.7% |
| 2011 Q2 | -2.71 CAD | -108.46% |
| 2011 Q4 | - CAD | 100.0% |
| 2010 Q4 | - CAD | 100.0% |
| 2010 Q3 | -1.42 CAD | 34.56% |
| 2010 Q2 | -2.17 CAD | 2.25% |
| 2010 FY | - CAD | 19.65% |
| 2010 Q1 | -2.22 CAD | 0.0% |
| 2009 Q2 | -1.93 CAD | 41.69% |
| 2009 FY | - CAD | 29.59% |
| 2009 Q3 | -3.93 CAD | -103.63% |
| 2009 Q1 | -3.31 CAD | 0.0% |
| 2009 Q4 | - CAD | 100.0% |
| 2008 Q1 | -0.66 CAD | 0.0% |
| 2008 Q4 | - CAD | 100.0% |
| 2008 Q3 | -25.20 CAD | -601.95% |
| 2008 FY | - CAD | -584.74% |
| 2008 Q2 | -3.59 CAD | -443.94% |
| 2007 Q1 | -0.15 CAD | 0.0% |
| 2007 Q3 | -0.50 CAD | -6229.11% |
| 2007 Q4 | - CAD | 100.0% |
| 2007 Q2 | -0.01 CAD | 94.73% |
| 2007 FY | - CAD | -15.15% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q2 | -0.90 CAD | -500.0% |
| 2006 Q4 | - CAD | 100.0% |
| 2006 Q1 | -0.15 CAD | 0.0% |
| 2006 Q3 | -0.45 CAD | 50.0% |